
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
HIVers taking a three-nucleoside regimen that includes Ziagen should switch to a more potent combination even if they currently have undetectable viral levels, researchers reported in The Journal of Infectious Diseases. They say a study of 744 HIVers has shown patients on a Ziagen-based nucleoside regimen had an 85% greater risk of eventual viral rebound than those taking Sustiva plus two nukes. Blood-fat levels also were higher among Ziagen users.
From our Sponsors
Most Popular
Be sure to follow
Plus on your favorite social platforms!
Facebook
Instagram
Twitter
Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now: https://advocatechannel.com
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video